Buy Cetilistat - API (CAS 282526-98-1) impurity reference standard from Spectrasynth Pharmachem. Custom synthesis available — enquire for pricing, COA and availability.
Application: Cetilistat has completed Phase 1 and 2 trials in the West and is currently in Phase 3 trials in Japan where it is partnered with Takeda. It is a drug designed to treat obesity. It acts in the same way as the older drug orlistat (Xenical) by inhibiting pancreatic lipase, an enzyme that breaks down triglycerides in the intestine.